Benjamin Crowley

Ben is a molecular biologist with previous experience in medical research on the immunogenetics of autoimmune diseases. 
His role is to assist in the coordination for an Innovative prograM to Prevent diAbetes-related foot ComplicaTions (IMPACT), Ben also contributes to other studies investigating the burden of diabetic foot disease on patients and health care systems.